Malaria and Neglected Diseases
This programme aims to expand our current scientific understanding of the most relevant diseases affecting humans, and their host-vector interactions, in order to support evidence-based policy-making for disease control and eventual elimination.
We focus on malaria and neglected diseases such as Chagas, Dengue, soil transmitted helminths and leishmaniasis.
We apply methods which include immunology, basic cell and molecular biology, omics, epidemiology, intervention trials with drugs, vaccines and diagnostic tools, surveillance and implementation science.
This program has international leadership in:
- Basic science for a better understanding of the biology and host-pathogen interactions of these diseases.
- Development and evaluation of new tools /strategies for the treatment and control of these diseases.
- Surveillance and implementation science.
Capacity building is included at all levels.
Research Groups
- PvREX - Plasmodium vivax and Exosome (Hernando A. del Portillo, Carmen Fernández Becerra)
- Parasite Glycobiology (Luis Izquierdo)
- Malaria Epigenetics Laboratory (Alfred Cortés)
- Nanoparticles and Malaria (Xavier Fernández Busquets)
- Immunology (Carlota Dobaño and Gemma Moncunill)
- Malaria Physiopathology and Genomics Group (Alfredo Mayor)
- Chagas Disease and other Emergent and Re-Emergent Diseases (Julio Alonso Padilla, Quim Gascon)
- Malaria Epidemiology, Operational Research and Implementation Science (Caterina Guinovart)
Our Team
Leadership
-
Hernando A. del Portillo ICREA Research Professor
-
Ana Requena Méndez Assistant Research Professor
Principal lnvestigators of the Programme
-
Julio Alonso Padilla Assistant Research Professor, Director of the Chagas Initiative
-
Alba Maria Antequera Associated Researcher
-
Azucena Bardají Associate Research Professor
-
Bàrbara Baro Assistant Research Professor
-
Quique Bassat Director General
-
CARLOS CHACCOUR Assistant Research Professor. BOHEMIA Co-PI and Chief Scientific Officer
-
Alfred Cortés ICREA Research Professor
-
Carlota Dobaño Research Professor
-
Carmen Fernández Associate Research Professor
-
Xavier Fernández Busquets Research Professor
-
Montserrat Gállego Associated Researcher
-
Quim Gascon Research Professor, Director of the Chagas Initiative
-
Caterina Guinovart Senior Advisor for Research and Implementation on malaria elimination
-
Luis Izquierdo Lázaro Associate Research Professor
-
Alfredo Mayor Research Professor
-
Clara Menéndez Research Professor, Director of the Maternal, Child and Reproductive Health Initiative and Programme
-
Gemma Moncunill Assistant Research Professor
-
Jose Muñoz Associate Research Professor
-
Claudio Parolo Associated Researcher
-
Regina Rabinovich Director of the Malaria Elimination Initiative
-
Davide Rasella Associate Research Professor and Head of the Health Impact Assessment and Evaluation Group
-
Elisa Sicuri Associate Research Professor
Highlighted Projects
ASINTMAL
Unravelling Disease Tolerance and Host Resistance in Afebrile 'P. falciparum' Infections: a Prospective Study in Mozambican Adults
MULTIPLY
MULTIple doses of IPTi Proposal: a Lifesaving high Yield intervention
Science4Pandemics
Citizens engagement digital platform for collective intelligence in pandemics
BOHEMIA
Broad One Health Endectocide-based Malaria Intervention in Africa
Impacto de las coinfecciones en el balance de respuestas de anticuerpos y linfocitos T helper a antígenos diana de inmunidad natural y vacunal frente a patógenos humanos prominentes
Project Code: PI20/00866
Euroleish.net
Control of Leishmaniasis. From bench to bedside and community
TESEO
New chemotherapy regimens and biomarkers for Chagas Disease
MENA Migrant Health
Transforming data collection and surveillance to drive migrant health research, care and policy
GenMoz
P. falciparum genomic intelligence in Mozambique
MESA
Sharing knowledge and catalyzing research towards a malaria-free world
RTS,S Vaccine Immunology Study
Study of immune correlates of protection against malaria after vaccination with RTS,S/AS01E: a comprehensive immunological arm of a Phase III double-blind, randomized, controlled multi-center trial
Other projects
See Past ProjectsHIDDENVIVAX
Novel organ-on-a-chip technology to study extracellular vesicles-mediated cryptic infections in Plasmodium vivax malaria
ADAM
Malaria mass and focal drug administration to advance malaria elimination in Mozambique: accelerating programmatic implementation and policy translation
EpiGen
Building Scalable Pathogen Genomic Epidemiology in Ethiopia
NHEPACHA
New Tools for the Diagnosis and Evaluation of Chagas Disease
Subclinical Infections in Children and Long Term Health Effects
Infection acquisition in early life and health outcomes in childhood - MARATO TV3
SMART
Identifying Severe Malaria with a new Aptamer-based Rapid diagnostic Test